IMARC Group, a leading market research company, has recently releases report titled “Cell Freezing Media Market Report by Product (DMSO, Glycerol, and Others), Application (Stem Cell Lines, Cancer Cell Lines, and Others), End Use (Pharmaceutical and Biotechnological Companies, Research and Academic Institutes, and Others), and Region 2023-2028”. The study provides a detailed analysis of the industry, including the global cell freezing media market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the cell freezing media market?
The global cell freezing media market size reached US$ 137.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 241.3 Million by 2028, exhibiting a growth rate (CAGR) of 9.5% during 2023-2028.
What is cell freezing media?
Cell freezing media is a specially formulated solution used to preserve cells for long-term storage at ultra-low temperatures, typically around -80°C or in liquid nitrogen at -196°C. This crucial component of cell biology research serves to protect the viability and functionality of cells, allowing them to be stored for extended periods without undergoing damage or deterioration. Cell freezing media consists of key components such as cryoprotectants, dimethyl sulfoxide (DMSO), and fetal bovine serum (FBS), which help shield cells from the harmful effects of ice crystal formation during freezing. DMSO acts as a permeating agent, allowing the cryoprotectants to enter the cells and prevent intracellular ice formation. FBS provides essential nutrients and growth factors that aid in cell recovery after thawing.
Request for a sample copy of this report: https://www.imarcgroup.com/cell-freezing-media-market/requestsample
What are the growth prospects and trends in the cell freezing media industry?
The shift of the pharmaceutical industry toward biopharmaceuticals, including monoclonal antibodies and cell therapies, has led to an increased demand for cell freezing media. These products require the preservation of cell lines for research, development, and production purposes. Additionally, biobanking initiatives and the establishment of extensive cell line repositories have become pivotal in research and diagnostics. Cell freezing media enables the long-term storage and maintenance of valuable cell lines for scientific exploration. Other than this, cell-based assays are integral to drug discovery and toxicology studies. The expansion of these applications in the pharmaceutical and biotechnology sectors fuels the demand for reliable cell freezing media. Besides this, the increasing focus on immunology and oncology research has led to a surge in the use of immune cells and cancer cell lines.
These specialized cells require precise preservation techniques, further bolstering the market. In line with this, increasing investments in healthcare infrastructure and research capabilities, especially in emerging economies, have expanded the reach of cell-based research, thereby increasing the demand for cell freezing media. Furthermore, collaborations between academic institutions, research organizations, and pharmaceutical companies have led to collaborative research projects that require standardized cell freezing protocols and media. Moreover, greater awareness and education about the importance of proper cell preservation techniques have led to increased adoption of cell freezing media among researchers and laboratories.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- DMSO
- Glycerol
- Others
Breakup by Application:
- Stem Cell Lines
- Cancer Cell Lines
- Others
Breakup by End Use:
- Pharmaceutical and Biotechnological Companies
- Research and Academic Institutes
- Others
Breakup by Region:
- North America (U.S. Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- AMSBIO
- BioLifeSolutions Inc
- Bio-Techne
- BPS Bioscience, Inc.
- Capricorn Scientific
- Cell Applications Inc.
- Cell Systems (AnaBios Corporation)
- HiMedia Laboratories
- Merck KGaA
- Sartorius AG
- STEMCELL Technologies
- Thermo Fisher Scientific Inc.
Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
